B. Braun invests US $ 1 billion in IV therapy production facilities
B. Braun Medical Inc., headquartered in Bethlehem, Pa., Announced Tuesday a $ 1 billion investment in new and improved manufacturing facilities for IV therapies.
The company will build a new manufacturing facility in Daytona Beach, Florida and upgrade existing facilities in Allentown, Pennsylvania and Irvine, California. The Solutions for Life initiative also includes a new sales facility in Daytona Beach and expansions to existing sales facilities in Breinigsville, Pennsylvania and Ontario, California.
“IV dehydration can cause serious complications for patients across the country, especially during times of public health emergencies,” said Senator Pat Toomey (R-PA). “B. Braun is making an important investment to address this problem by expanding production capacity and improving the ability to deliver IV fluids on-demand and on-demand. “
Efforts also emphasize sustainability and ensure global IV fluids security. B. Braun has received Food and Drug Administration (FDA) approval for IV fluids from European institutions should this be required in the future.
“As a family-owned medical technology and pharmaceutical company, B. Braun believes in longevity, stability and partnership,” said Caroll H. Neubauer, CEO and Chairman of the Board of B. Braun. “These core values drive our investments to prevent future shortages of US IV fluids and our work with policy makers, healthcare providers and supply chain partners to deliver these life-saving fluids. Solutions for Life is our commitment to ensuring a constant supply of vital saline and other IV fluids that hospitals and healthcare systems rely on to care for patients. “